vimarsana.com

Page 18 - Joel Perlmutter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Doctors Resign From FDA Panel After Aducanumab Approval

Carolyn Mandlman

Apr 16, 2021 Lila Mildred Meyers will become a bat mitzvah on May 15, 2021. Lila is the daughter of Mrs. Morgan and Honorable Matthew and big sister of Greyson and Jack Meyers of Creve Coeur. Lila is the granddaughter of Mrs. Judy and Dr. Mark Meyers of Chesterfield and Mrs. Peggy and Mr. Robert Wynne of…

Parkinson s Motor Function Improved with Focused Ultrasound

Dec 29, 2020 But adverse events were frequent and persistent, trial shows Focused ultrasound subthalamotomy improved motor function in Parkinson’s disease, but it also led to multiple adverse events that persisted in some patients, a small randomized double-blind trial found. “Focused ultrasound subthalamotomy in one hemisphere improved motor features of Parkinson’s disease in selected patients with asymmetric signs,” wrote Raul Martinez-Fernandez, MD, PhD, of CEU San Pablo University in Mostoles, Spain, and co-authors in . “Adverse events included speech and gait disturbances, weakness on the treated side, and dyskinesia.” Patients with asymmetric Parkinson’s disease who had motor signs not fully controlled with medication and who were not candidates for deep-brain stimulation surgery were randomized to focused ultrasound subthalamotomy on the side opposite their main motor signs (n=27) or a sham procedure (n=13).

Parkinson s Motor Symptoms Improve With Focused Ultrasound

email article Focused ultrasound in one brain hemisphere improved motor function on the opposite side of the body in people with Parkinson s disease, but led to frequent, persistent adverse events, a small sham-controlled trial showed. In a select group of patients with markedly asymmetric Parkinson s signs, focused ultrasound subthalamotomy led to a significant improvement in Movement Disorder Society-Unified Parkinson s Disease Rating Scale motor scores (MDS-UPDRS III) at 4 months compared with sham treatment, with a between-group difference of 8.1 points (95% CI 6.0-10.3, P

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.